MarketScreener Editorial Features MannKind Corporation
Equities
MNKD
US56400P7069
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.460 USD | -7.61% |
|
+4.80% | -3.70% |
| 01-08 | MannKind provides business updates and 2026 growth drivers | RE |
| 12-23 | MannKind Says FDA Approves Furoscix Autoinjector Use for Pediatric Patients With Fluid Retention | MT |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition